When considering therapy for diffuse large b-cell lymphoma (DLBCL), what determines the best treatment for YOU? In this 30-minute webinar, Dr. Loretta Nastoupil will share key decision-making factors, emerging research, and tools for partnering with your healthcare team.
Watch online on Tuesday, October 5 at 1 PM Eastern (10 AM PT, 12 PM CT) for a 30-minute virtual webinar and download the guide before the webinar airs here.
Guest
Partners
 |
 |
This program is brought to you by the Patient Empowerment Network. This program is made possible in part by funding provided by Incyte Corporation and MorphoSys, Inc., and through generous donations from people like you.
